YapHYBlumenscheinGRKeatingMJHortobagyiGNTashimaCKLooTL. Vinblastine given as a continuous 5-day infusion in the treatment of refractory advanced breast cancer. Cancer Treat Rep1980; 64: 279–83.
2.
YoungJAHowellSBGreenMR. Pharmacokinetics and toxicity of 5-day continuous infusion of vinblastine. Cancer Chemother Pharmacol1984; 12: 43–5.
3.
LokichJJZipoliTEPerriJBotheA. Protracted vinblastine infusion phase I-II study in malignant melanoma and other tumors. Am J Clin Oncol1984; 7: 551–3.
4.
RatainMJVogelzangNJ. Phase 1 and pharmacological study of vinblastine by prolonged continuous infusion. Cancer Res1986; 46: 4827–30.
5.
BlackJBuechterDDChinnJWGardJThurstonDE. Studies on the stability of vinblastine sulfate in aqueous solution. J Pharm Sci (in press).
6.
GreeniusHFMcIntyreRWBeerCT. The preparation of vinblastine-4-acetyl-t and its distribution in the blood of rats. J Med Chem1968; 11: 254–7.
